Safety and tolerance of ocular administration of recombinant alpha interferon.
AUTOR(ES)
Turner, R B
RESUMO
The safety, tolerance, and levels of drug in the nasal cavity produced by an ocular formulation of interferon were determined at four dosages in a placebo-controlled, double-masked trial. Interferon given by the ocular route was generally well tolerated, although a dose-related occurrence of subjective symptoms was detected.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=171501Documentos Relacionados
- Safety and tolerance of recombinant leukocyte A interferon in bone marrow transplant recipients.
- Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon.
- Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.
- Antibacterial activity of recombinant murine beta interferon.
- Treatment of Waldenström's macroglobulinemia with alpha interferon.
